Structural Heart Devices Market

Structural Heart Devices Market (Type: Salt-based Ion Exchanger Softener and Salt-free Water Softener) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Structural Heart Devices Market Outlook 2031

  • The industry was valued at US$ 11.9 Bn in 2022
  • It is estimated to grow at a CAGR of 6.5% from 2023 to 2031 and reach US$ 20.5 Bn by the end of 2031

Analyst Viewpoint

Rise in prevalence of structural heart diseases is fueling the structural heart devices market size. The impact of new structural heart interventions and product launches in the field of valve replacement is expected to remain high on the market, globally.

Technological breakthroughs, such as TAVR and hybrid therapy, are likely to provide lucrative structural heart devices market opportunities to vendors. TAVR is a major breakthrough in minimally invasive medical therapy.

Companies with research & development capabilities and technological prowess are estimated to gather momentum and profitability in the structural heart devices industry.

Market Introduction

Structural heart procedures may open narrowed heart valves, close holes in the heart, or replace damaged valves. Structural heart devices usually feature vascular closure devices and dual-lumen catheters.

These devices can be implanted through a minimally invasive approach. They are employed in the treatment and management of structural heart diseases including aortic valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, mitral valve disease, and tricuspid and pulmonic valve disease.

Demand for structural heart devices has seen a paradigm shift with the advent of non-invasive procedures to treat aortic stenosis and mitral regurgitation. Surge in investment in minimally-invasive heart valve technologies is expected to spur the structural heart devices market growth in the near future.

Attribute Detail
Drivers
  • Rise in Prevalence of Structural Heart Diseases
  • Approval and Launch of New Devices

Rise in Prevalence of Structural Heart Diseases Fueling Structural Heart Devices Market Revenue

Structural heart diseases affect the valves, walls, chambers, or muscles of the heart. These diseases include aortic valve disease, atrial septal defect, and ventricular septal defect. The prevalence of structural heart disease is high among newborns.

Heart valve disease is the most common type of structural heart disease. It affects about 2.5% of all people in the U.S. More than 2 million people in the country have a leaky heart valve. Additionally, about 1.4 million adults and 1 million children in the U.S. have a congenital heart condition.

Surge in adoption of minimally invasive devices is driving the structural heart devices market development. Minimally invasive approaches can be used for structural heart disease treatment.

These approaches help avoid opening the chest and breastbone. A flexible, hollow tube (catheter) is employed to access the heart through a blood vessel in the groin.

In October 2023, Abbott announced data from the TRILUMINATE pivotal trial that reinforced the safety and effectiveness of the TriClip transcatheter edge-to-edge repair (TEER) system for patients with symptomatic, severe tricuspid regurgitation despite optimal medical therapy.

Hence, R&D in minimally invasive heart devices in the treatment of mitral and tricuspid valve disease is propelling the market expansion.

Approval and Launch of New Devices Boosting Market Progress

Structural heart devices are common in newborn babies. For example, an atrial septal defect is a birth defect of the heart in which there is a hole in the wall (septum) that divides the upper chambers (atria) of the heart.

Atrial septal defect has a birth prevalence of 2.5/1000 live births, 25% to 30% of which are present in adulthood. Thus, rise in prevalence of atrial septal defects is boosting the structural heart devices market trajectory.

In January 2024, Occlutech, a Swedish medical device company focused on structural heart disease, received U.S. Food and Drug Administration (FDA) approval for its ASD Occluder for the treatment of atrial septal defects.

The company also gained FDA approval for its Pistol Pusher delivery system, and the two offerings will be commercialized throughout the U.S. as part of an exclusive arrangement with B. Braun Interventional Systems. Hence, approval and launch of new devices is augmenting the structural heart devices market statistics.

Regional Outlook

Attribute Detail
Leading Region North America

According to the latest structural heart devices market insights, North America held largest share in 2022. R&D of new products is propelling the market dynamics of the region.

In July 2023, CardioPrecision entered the U.S. market with the introduction of its technology for use in Endoscopic Vessel Harvesting (EVH) during coronary artery bypass grafting (CABG) surgery at the Massachusetts General Hospital in Boston.

The Glasgow-based company is focused on less invasive treatment of structural heart disease.

Surge in awareness about structural heart diseases and favorable reimbursement policies for devices are also boosting the structural heart devices market share in North America.

Several public and privately held organizations are conducting awareness programs highlighting the risk factors, symptoms, diagnosis, and treatment options for valvular heart disease and other heart defects.

Analysis of Key Players

Major players are focused on the design, manufacture, and commercialization of disruptive catheter-based technologies for the treatment of structural heart disease.

The structural heart devices market landscape is highly consolidated, with the presence of major players including Medtronic, Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova plc, Lepu Medical, Micro Interventional Devices, Inc., LifeTech Scientific Corporation, and CryoLife, Inc.

These companies have been profiled in the structural heart devices market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.

Key Developments in Structural Heart Devices Market

  • In January 2024, Integer Holdings Corp. finalized a deal to acquire Pulse Technologies, a privately held contract manufacturing company that specializes in materials and coatings used to develop and manufacture medical devices to serve healthcare markets such as structural heart disease, electrophysiology, leadless pacing and neuromodulation
  • In December 2023, Edwards Lifesciences announced to spin off its critical care unit at the end of 2024 to concentrate on its larger heart devices business. Transcatheter aortic valve replacement (TAVR) device, the company's lead product, has been facing rising competition from Abbott, Boston Scientific, and Medtronic. The device is used to perform minimally invasive surgery for people with heart valve disease.

Structural Heart Devices Market Snapshot

Attribute Detail
Market Size in 2022 US$ 11.9 Bn
Market Forecast (Value) in 2031 US$ 20.5 Bn
Growth Rate (CAGR) 6.5%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Tons US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • By Product
    • Biological/Tissue Valves
      • Transcatheter Heart Valves
      • Surgical Heart Valves
    • Mechanical Heart Valves
    • Annuloplasty Rings
    • Occluders
    • Accessories
  • By Procedure
    • Replacement Procedures
    • Repair Procedures
  • By Indication
    • Valve Stenosis
    • Valve Regurgitation
    • Cardiomyopathy
    • Congenital Heart Defects
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries
Companies Profiled
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • LivaNova plc
  • Lepu Medical
  • Micro Interventional Devices, Inc.
  • LifeTech Scientific Corporation
  • CryoLife, Inc.
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global structural heart devices market in 2022?

It was valued at US$ 11.9 Bn in 2022

How is the structural heart devices industry expected to grow during the forecast period?

It is anticipated to grow at a CAGR of 6.5% from 2023 to 2031

What are the key factors driving the demand for structural heart devices?

Rise in prevalence of structural heart diseases and approval and launch of new devices

Which was the major region in the global structural heart devices landscape in 2022?

North America was the leading region in 2022

Who are the prominent structural heart device manufacturers?

Medtronic, Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova plc, Lepu Medical, Micro Interventional Devices, Inc., LifeTech Scientific Corporation, and CryoLife, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Structural Heart Devices Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Structural Heart Devices Market Analysis and Forecast, 2017-2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Structural Heart Devices Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product, 2017-2031

            6.3.1. Biological/Tissue Valves

                6.3.1.1. Transcatheter Heart Valves

                6.3.1.2. Surgical Heart Valves

            6.3.2. Mechanical Heart Valves

            6.3.3. Annuloplasty Rings

            6.3.4. Occluders

            6.3.5. Accessories

        6.4. Market Attractiveness Analysis, by Product

    7. Global Structural Heart Devices Market Analysis and Forecast, by Procedure

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Procedure, 2017-2031

            7.3.1. Replacement Procedures

            7.3.2. Repair Procedures

        7.4. Market Attractiveness Analysis, by Procedure

    8. Global Structural Heart Devices Market Analysis and Forecast, by Indication

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by Indication, 2017-2031

            8.3.1. Valve Stenosis

            8.3.2. Valve Regurgitation

            8.3.3. Cardiomyopathy

            8.3.4. Congenital Heart Defects

            8.3.5. Others

        8.4. Market Attractiveness Analysis, by Indication

    9. Global Structural Heart Devices Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017-2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Structural Heart Devices Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Product, 2017-2031

            10.3.1. Biological/Tissue Valves

                10.3.1.1. Transcatheter Heart Valves

                10.3.1.2. Surgical Heart Valves

            10.3.2. Mechanical Heart Valves

            10.3.3. Annuloplasty Rings

            10.3.4. Occluders

            10.3.5. Accessories

        10.4. Market Value Forecast, by Procedure, 2017-2031

            10.4.1. Replacement Procedures

            10.4.2. Repair Procedures

        10.5. Market Value Forecast, by Indication, 2017-2031

            10.5.1. Valve Stenosis

            10.5.2. Valve Regurgitation

            10.5.3. Cardiomyopathy

            10.5.4. Congenital Heart Defects

            10.5.5. Others

        10.6. Market Value Forecast, by Country, 2017-2031

            10.6.1. U.S.

            10.6.2. Canada

        10.7. Market Attractiveness Analysis

            10.7.1. By Product

            10.7.2. By Procedure

            10.7.3. By Indication

            10.7.4. By Country

    11. Europe Structural Heart Devices Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Product, 2017-2031

            11.3.1. Biological/Tissue Valves

                11.3.1.1. Transcatheter Heart Valves

                11.3.1.2. Surgical Heart Valves

            11.3.2. Mechanical Heart Valves

            11.3.3. Annuloplasty Rings

            11.3.4. Occluders

            11.3.5. Accessories

        11.4. Market Value Forecast, by Procedure, 2017-2031

            11.4.1. Replacement Procedures

            11.4.2. Repair Procedures

        11.5. Market Value Forecast, by Indication, 2017-2031

            11.5.1. Valve Stenosis

            11.5.2. Valve Regurgitation

            11.5.3. Cardiomyopathy

            11.5.4. Congenital Heart Defects

            11.5.5. Others

        11.6. Market Value Forecast, by Country/Sub-region, 2017-2031

            11.6.1. Germany

            11.6.2. U.K.

            11.6.3. France

            11.6.4. Italy

            11.6.5. Spain

            11.6.6. Rest of Europe

        11.7. Market Attractiveness Analysis

            11.7.1. By Product

            11.7.2. By Procedure

            11.7.3. By Indication

            11.7.4. By Country/Sub-region

    12. Asia Pacific Structural Heart Devices Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Product, 2017-2031

            12.3.1. Biological/Tissue Valves

                12.3.1.1. Transcatheter Heart Valves

                12.3.1.2. Surgical Heart Valves

            12.3.2. Mechanical Heart Valves

            12.3.3. Annuloplasty Rings

            12.3.4. Occluders

            12.3.5. Accessories

        12.4. Market Value Forecast, by Procedure, 2017-2031

            12.4.1. Replacement Procedures

            12.4.2. Repair Procedures

        12.5. Market Value Forecast, by Indication, 2017-2031

            12.5.1. Valve Stenosis

            12.5.2. Valve Regurgitation

            12.5.3. Cardiomyopathy

            12.5.4. Congenital Heart Defects

            12.5.5. Others

        12.6. Market Value Forecast, by Country/Sub-region, 2017-2031

            12.6.1. China

            12.6.2. Japan

            12.6.3. India

            12.6.4. Australia & New Zealand

            12.6.5. Rest of Asia Pacific

        12.7. Market Attractiveness Analysis

            12.7.1. By Product

            12.7.2. By Procedure

            12.7.3. By Indication

            12.7.4. By Country/Sub-region

    13. Latin America Structural Heart Devices Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Product, 2017-2031

            13.3.1. Biological/Tissue Valves

                13.3.1.1. Transcatheter Heart Valves

                13.3.1.2. Surgical Heart Valves

            13.3.2. Mechanical Heart Valves

            13.3.3. Annuloplasty Rings

            13.3.4. Occluders

            13.3.5. Accessories

        13.4. Market Value Forecast, by Procedure, 2017-2031

            13.4.1. Replacement Procedures

            13.4.2. Repair Procedures

        13.5. Market Value Forecast, by Indication, 2017-2031

            13.5.1. Valve Stenosis

            13.5.2. Valve Regurgitation

            13.5.3. Cardiomyopathy

            13.5.4. Congenital Heart Defects

            13.5.5. Others

        13.6. Market Value Forecast, by Country/Sub-region, 2017-2031

            13.6.1. Brazil

            13.6.2. Mexico

            13.6.3. Rest of Latin America

        13.7. Market Attractiveness Analysis

            13.7.1. By Product

            13.7.2. By Procedure

            13.7.3. By Indication

            13.7.4. By Country/Sub-region

    14. Middle East & Africa Structural Heart Devices Market Analysis and Forecast

        14.1. Introduction

        14.2. Key Findings

        14.3. Market Value Forecast, by Product, 2017-2031

            14.3.1. Biological/Tissue Valves

                14.3.1.1. Transcatheter Heart Valves

                14.3.1.2. Surgical Heart Valves

            14.3.2. Mechanical Heart Valves

            14.3.3. Annuloplasty Rings

            14.3.4. Occluders

            14.3.5. Accessories

        14.4. Market Value Forecast, by Procedure, 2017-2031

            14.4.1. Replacement Procedures

            14.4.2. Repair Procedures

        14.5. Market Value Forecast, by Indication, 2017-2031

            14.5.1. Valve Stenosis

            14.5.2. Valve Regurgitation

            14.5.3. Cardiomyopathy

            14.5.4. Congenital Heart Defects

            14.5.5. Others

        14.6. Market Value Forecast, by Country/Sub-region, 2017-2031

            14.6.1. GCC Countries

            14.6.2. South Africa

            14.6.3. Rest of Middle East & Africa

        14.7. Market Attractiveness Analysis

            14.7.1. By Product

            14.7.2. By Procedure

            14.7.3. By Indication

            14.7.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. Medtronic

                15.3.1.1. Company Overview

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Financial Overview

                15.3.1.5. Strategic Overview

            15.3.2. Abbott

                15.3.2.1. Company Overview

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Financial Overview

                15.3.2.5. Strategic Overview

            15.3.3. Boston Scientific Corporation

                15.3.3.1. Company Overview

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Financial Overview

                15.3.3.5. Strategic Overview

            15.3.4. Edwards Lifesciences Corporation

                15.3.4.1. Company Overview

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Financial Overview

                15.3.4.5. Strategic Overview

            15.3.5. LivaNova plc

                15.3.5.1. Company Overview

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Financial Overview

                15.3.5.5. Strategic Overview

            15.3.6. Lepu Medical

                15.3.6.1. Company Overview

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Financial Overview

                15.3.6.5. Strategic Overview

            15.3.7. Micro Interventional Devices, Inc.

                15.3.7.1. Company Overview

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Financial Overview

                15.3.7.5. Strategic Overview

            15.3.8. LifeTech Scientific Corporation

                15.3.8.1. Company Overview

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Financial Overview

                15.3.8.5. Strategic Overview

            15.3.9. CryoLife, Inc.

                15.3.9.1. Company Overview

                15.3.9.2. Product Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Financial Overview

                15.3.9.5. Strategic Overview

    List of Tables

    Table 01: Global Structural Heart Devices Market Size (US$ Mn) Forecast, by Product, 2017-2031

    Table 02: Global Structural Heart Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2031

    Table 03: Global Structural Heart Devices Market Size (US$ Mn) Forecast, by Indication, 2017-2031

    Table 04: Global Structural Heart Devices Market Size (US$ Mn) Forecast, by Region, 2017-2031

    Table 05: North America Structural Heart Devices Market Size (US$ Mn) Forecast, by Country, 2017-2031

    Table 06: North America Structural Heart Devices Market Size (US$ Mn) Forecast, by Product, 2017-2031

    Table 07: North America Structural Heart Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2031

    Table 08: North America Structural Heart Devices Market Size (US$ Mn) Forecast, by Indication, 2017-2031

    Table 09: Europe Structural Heart Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 10: Europe Structural Heart Devices Market Size (US$ Mn) Forecast, by Product, 2017-2031

    Table 11: Europe Structural Heart Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2031

    Table 12: Europe Structural Heart Devices Market Size (US$ Mn) Forecast, by Indication, 2017-2031

    Table 13: Asia Pacific Structural Heart Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 14: Asia Pacific Structural Heart Devices Market Size (US$ Mn) Forecast, by Product, 2017-2031

    Table 15: Asia Pacific Structural Heart Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2031

    Table 16: Asia Pacific Structural Heart Devices Market Size (US$ Mn) Forecast, by Indication, 2017-2031

    Table 17: Latin America Structural Heart Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 18: Latin America Structural Heart Devices Market Size (US$ Mn) Forecast, by Product, 2017-2031

    Table 19: Latin America Structural Heart Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2031

    Table 20: Latin America Structural Heart Devices Market Size (US$ Mn) Forecast, by Indication, 2017-2031

    Table 21: Middle East & Africa Structural Heart Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 22: Middle East & Africa Structural Heart Devices Market Size (US$ Mn) Forecast, by Product, 2017-2031

    Table 23: Middle East & Africa Structural Heart Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2031

    Table 24: Middle East & Africa Structural Heart Devices Market Size (US$ Mn) Forecast, by Indication, 2017-2031

    List of Figures

    Figure 01: Global Structural Heart Devices Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031

    Figure 02: Global Structural Heart Devices Market Revenue (US$ Mn), by Product, 2022

    Figure 03: Global Structural Heart Devices Market Value Share, by Product, 2022

    Figure 04: Global Structural Heart Devices Market Revenue (US$ Mn), by Procedure, 2022

    Figure 05: Global Structural Heart Devices Market Value Share, by Procedure, 2022

    Figure 06: Global Structural Heart Devices Market Revenue (US$ Mn), by Indication, 2022

    Figure 07: Global Structural Heart Devices Market Value Share, by Indication, 2022

    Figure 08: Global Structural Heart Devices Market Value Share, by Region, 2022

    Figure 09: Global Structural Heart Devices Market Value (US$ Mn) Forecast, 2017-2031

    Figure 10: Global Structural Heart Devices Market Value Share Analysis, by Product, 2022 and 2031

    Figure 11: Global Structural Heart Devices Market Attractiveness Analysis, by Product, 2023-2031

    Figure 12: Global Structural Heart Devices Market Value Share Analysis, by Procedure, 2022 and 2031

    Figure 13: Global Structural Heart Devices Market Attractiveness Analysis, by Procedure, 2023-2031

    Figure 14: Global Structural Heart Devices Market Value Share Analysis, by Indication, 2022 and 2031

    Figure 15: Global Structural Heart Devices Market Attractiveness Analysis, by Indication, 2023-2031

    Figure 16: Global Structural Heart Devices Market Value Share Analysis, by Region, 2022 and 2031

    Figure 17: Global Structural Heart Devices Market Attractiveness Analysis, by Region, 2023-2031

    Figure 18: North America Structural Heart Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

    Figure 19: North America Structural Heart Devices Market Attractiveness Analysis, by Country, 2023-2031

    Figure 20: North America Structural Heart Devices Market Value Share Analysis, by Country, 2022 and 2031

    Figure 21: North America Structural Heart Devices Market Value Share Analysis, by Product, 2022 and 2031

    Figure 22: North America Structural Heart Devices Market Value Share Analysis, by Procedure, 2022 and 2031

    Figure 23: North America Structural Heart Devices Market Value Share Analysis, by Indication, 2022 and 2031

    Figure 24: North America Structural Heart Devices Market Attractiveness Analysis, by Product, 2023-2031

    Figure 25: North America Structural Heart Devices Market Attractiveness Analysis, by Procedure, 2023-2031

    Figure 26: North America Structural Heart Devices Market Attractiveness Analysis, by Indication, 2023-2031

    Figure 27: Europe Structural Heart Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

    Figure 28: Europe Structural Heart Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 29: Europe Structural Heart Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 30: Europe Structural Heart Devices Market Value Share Analysis, by Product, 2022 and 2031

    Figure 31: Europe Structural Heart Devices Market Value Share Analysis, by Procedure, 2022 and 2031

    Figure 32: Europe Structural Heart Devices Market Value Share Analysis, by Indication, 2022 and 2031

    Figure 33: Europe Structural Heart Devices Market Attractiveness Analysis, by Product, 2023-2031

    Figure 34: Europe Structural Heart Devices Market Attractiveness Analysis, by Procedure, 2023-2031

    Figure 35: Europe Structural Heart Devices Market Attractiveness Analysis, by Indication, 2023-2031

    Figure 36: Asia Pacific Structural Heart Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

    Figure 37: Asia Pacific Structural Heart Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 38: Asia Pacific Structural Heart Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 39: Asia Pacific Structural Heart Devices Market Value Share Analysis, by Product, 2022 and 2031

    Figure 40: Asia Pacific Structural Heart Devices Market Value Share Analysis, by Procedure, 2022 and 2031

    Figure 41: Asia Pacific Structural Heart Devices Market Value Share Analysis, by Indication, 2022 and 2031

    Figure 42: Asia Pacific Structural Heart Devices Market Attractiveness Analysis, by Product, 2023-2031

    Figure 43: Asia Pacific Structural Heart Devices Market Attractiveness Analysis, by Procedure, 2023-2031

    Figure 44: Asia Pacific Structural Heart Devices Market Attractiveness Analysis, by Indication, 2023-2031

    Figure 45: Latin America Structural Heart Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

    Figure 46: Latin America Structural Heart Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 47: Latin America Structural Heart Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 48: Latin America Structural Heart Devices Market Value Share Analysis, by Product, 2022 and 2031

    Figure 49: Latin America Structural Heart Devices Market Value Share Analysis, by Procedure, 2022 and 2031

    Figure 50: Latin America Structural Heart Devices Market Value Share Analysis, by Indication, 2022 and 2031

    Figure 51: Latin America Structural Heart Devices Market Attractiveness Analysis, by Product, 2023-2031

    Figure 52: Latin America Structural Heart Devices Market Attractiveness Analysis, by Procedure, 2023-2031

    Figure 53: Latin America Structural Heart Devices Market Attractiveness Analysis, by Indication, 2023-2031

    Figure 54: Middle East & Africa Structural Heart Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

    Figure 55: Middle East & Africa Structural Heart Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 56: Middle East & Africa Structural Heart Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 57: Middle East & Africa Structural Heart Devices Market Value Share Analysis, by Product, 2022 and 2031

    Figure 58: Middle East & Africa Structural Heart Devices Market Value Share Analysis, by Procedure, 2022 and 2031

    Figure 59: Middle East & Africa Structural Heart Devices Market Value Share Analysis, by Indication, 2022 and 2031

    Figure 60: Middle East & Africa Structural Heart Devices Market Attractiveness Analysis, by Product, 2023-2031

    Figure 61: Middle East & Africa Structural Heart Devices Market Attractiveness Analysis, by Procedure, 2023-2031

    Figure 62: Middle East & Africa Structural Heart Devices Market Attractiveness Analysis, by Indication, 2023-2031

Copyright © Transparency Market Research, Inc. All Rights reserved